Fagan Associates’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-14,651
| Closed | -$1.97M | – | 139 |
|
|
2025
Q2 | $1.97M | Sell |
14,651
-701
| -5% | -$94.7K | 0.31% | 65 |
|
|
2025
Q1 | $2.24M | Sell |
15,352
-887
| -5% | -$129K | 0.37% | 64 |
|
|
2024
Q4 | $2.23M | Buy |
16,239
+218
| +1% | +$31.9K | 0.35% | 66 |
|
|
2024
Q3 | $2.47M | Sell |
16,021
-247
| -2% | -$37.4K | 0.41% | 63 |
|
|
2024
Q2 | $2.37M | Sell |
16,268
-212
| -1% | -$30.4K | 0.41% | 62 |
|
|
2024
Q1 | $2.43M | Sell |
16,480
-108
| -0.7% | -$15.5K | 0.46% | 59 |
|
|
2023
Q4 | $2.26M | Sell |
16,588
-559
| -3% | -$72.7K | 0.49% | 53 |
|
|
2023
Q3 | $2.21M | Buy |
17,147
+46
| +0.3% | +$6.11K | 0.53% | 48 |
|
|
2023
Q2 | $2.27M | Sell |
17,101
-105
| -0.6% | -$13.8K | 0.55% | 46 |
|
|
2023
Q1 | $2.23M | Buy |
17,206
+1,779
| +12% | +$232K | 0.55% | 48 |
|
|
2022
Q4 | $2.1M | Buy |
15,427
+1,258
| +9% | +$167K | 0.56% | 48 |
|
|
2022
Q3 | $1.72M | Buy |
14,169
+284
| +2% | +$36.6K | 0.48% | 48 |
|
|
2022
Q2 | $1.78M | Buy |
13,885
+7,453
| +116% | +$977K | 0.48% | 48 |
|
|
2022
Q1 | $881K | Sell |
6,432
-163
| -2% | -$21.6K | 0.18% | 79 |
|
|
2021
Q4 | $929K | Buy |
6,595
+373
| +6% | +$49.5K | 0.18% | 78 |
|
|
2021
Q3 | $792K | Buy |
6,222
+801
| +15% | +$106K | 0.17% | 83 |
|
|
2021
Q2 | $683K | Buy |
5,421
+1,137
| +27% | +$139K | 0.15% | 91 |
|
|
2021
Q1 | $500K | Sell |
4,284
-5
| -0.1% | -$577 | 0.12% | 94 |
|
|
2020
Q4 | $486K | Buy |
4,289
+12
| +0.3% | +$1.31K | 0.12% | 88 |
|
|
2020
Q3 | $451K | Sell |
4,277
-67
| -2% | -$7.05K | 0.13% | 84 |
|
|
2020
Q2 | $435K | Buy |
4,344
+13
| +0.3% | +$1.28K | 0.14% | 83 |
|
|
2020
Q1 | $384K | Buy |
4,331
+189
| +5% | +$18.4K | 0.15% | 81 |
|
|
2019
Q4 | $422K | Sell |
4,142
-210
| -5% | -$20.2K | 0.14% | 92 |
|
|
2019
Q3 | $392K | Buy |
4,352
+148
| +4% | +$13.5K | 0.15% | 90 |
|
|
2019
Q2 | $389K | Sell |
4,204
-96
| -2% | -$8.63K | 0.16% | 94 |
|
|
2019
Q1 | $395K | Buy |
4,300
+12
| +0.3% | +$1.08K | 0.17% | 94 |
|
|
2018
Q4 | $371K | Buy |
4,288
+15
| +0.4% | +$1.36K | 0.19% | 91 |
|
|
2018
Q3 | $407K | Sell |
4,273
-87
| -2% | -$7.86K | 0.17% | 99 |
|
|
2018
Q2 | $364K | Sell |
4,360
-107
| -2% | -$8.87K | 0.16% | 96 |
|
|
2018
Q1 | $364 | Sell |
4,467
-18
| -0.4% | -$1.53K | 0.16% | 87 |
|
|
2017
Q4 | $371 | Buy |
4,485
+44
| +1% | +$3.63K | 0.15% | 91 |
|
|
2017
Q3 | $363K | Buy |
4,441
+12
| +0.3% | +$964 | 0.18% | 91 |
|
|
2017
Q2 | $351K | Buy |
4,429
+13
| +0.3% | +$990 | 0.18% | 91 |
|
|
2017
Q1 | $328K | Sell |
4,416
-174
| -4% | -$12.7K | 0.18% | 88 |
|
|
2016
Q4 | $316K | Buy |
4,590
+15
| +0.3% | +$1.04K | 0.18% | 91 |
|
|
2016
Q3 | $330K | Sell |
4,575
-36
| -0.8% | -$2.65K | 0.2% | 84 |
|
|
2016
Q2 | $331K | Buy |
4,611
+14
| +0.3% | +$986 | 0.21% | 79 |
|
|
2016
Q1 | $312K | Sell |
4,597
-63
| -1% | -$4.22K | 0.21% | 79 |
|
|
2015
Q4 | $336K | Buy |
4,660
+34
| +0.7% | +$2.4K | 0.22% | 77 |
|
|
2015
Q3 | $306K | Buy |
4,626
+14
| +0.3% | +$1.02K | 0.22% | 79 |
|
|
2015
Q2 | $343K | Buy |
4,612
+12
| +0.3% | +$889 | 0.23% | 79 |
|
|
2015
Q1 | $333K | Sell |
4,600
-40
| -0.9% | -$2.85K | 0.25% | 78 |
|
|
2014
Q4 | $317K | Buy |
4,640
+63
| +1% | +$4.22K | 0.25% | 76 |
|
|
2014
Q3 | $293K | Buy |
4,577
+25
| +0.5% | +$1.57K | 0.24% | 78 |
|
|
2014
Q2 | $177K | Buy |
4,552
+12
| +0.3% | +$705 | 0.15% | 83 |
|
|
2014
Q1 | $266K | Buy |
+4,540
| New | +$262K | 0.23% | 77 |
|
Other funds holding XLV
NAM
Fagan Associates's XLV Position: Q3 2025 in Review
Fagan Associates sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q3 2025, closing a stake of 14,651 shares — an estimated $1.97M sold.
Fagan Associates first reported a position in XLV in Q1 2014 and held it in 46 quarters. The position peaked at $2.47M in Q3 2024. 1,647 funds tracked by Wall St. Rank hold XLV as of Q3 2025.
- Fagan Associates reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q3 2025 after selling out during the quarter.
- Fagan Associates sold 14,651 State Street Health Care Select Sector SPDR ETF shares in Q3 2025, an estimated $1.97M.
- Fagan Associates first reported a position in State Street Health Care Select Sector SPDR ETF in Q1 2014 and held it in 46 quarters.
- Fagan Associates's State Street Health Care Select Sector SPDR ETF position peaked at $2.47M in Q3 2024.
- 1,647 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q3 2025.
Based on Fagan Associates's 13F filing for Q3 2025, filed 14 Nov 2025.